Key result
Oxaliplatin demonstrates activity against digestive cancers and shows real or potential synergism when combined with other cytotoxic or molecularly targeted agents.
Population
Preclinical and clinical data regarding digestive cancers
Design
Review
Authors
Loading...
Oxaliplatin remains relevant in digestive cancers; extends synergy data but leaves optimal targeted combinations open for prospective trials.
Oxaliplatin remains a relevant chemotherapeutic agent with potential synergistic effects when combined with molecularly targeted therapies for digestive cancers.
Alcindor et al. (2011) conducted a review in Digestive cancers. Oxaliplatin was evaluated. Oxaliplatin demonstrates activity against digestive cancers and shows real or potential synergism when combined with other cytotoxic or molecularly targeted agents.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: